• Patient Action Center
  • Seniors Rising Now
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate

Tag: ICER

Patients Rising Now Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Relapsing Forms of Multiple Sclerosis

Patients Rising Now Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Relapsing Forms of Multiple Sclerosis

Nov 2, 2022 | ICER

On October 17, 2022, ICER released its draft evidence report, “Oral and Monoclonal Antibody Treatments for Relapsing Forms of Multiple Sclerosis.” This document provides a framework for considering what aspects of ICER’s review are important to people with multiple...
Read more
Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Menopause Vasomotor Symptoms

Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Menopause Vasomotor Symptoms

Oct 25, 2022 | Featured, ICER, Uncategorized

On October 11, 2022, ICER released its draft evidence report, “Fezolinetant for Moderate to Severe Vasomotor Symptoms Associated with Menopause.” This document provides a framework for considering what aspects of ICER’s review are important to women and their...
Read more
Podcast 28: Empowering Chronic Disease in the Workplace

Podcast 28: Empowering Chronic Disease in the Workplace

Sep 5, 2020 | COVID-19, Featured

On this episode of the podcast, Terry and Bob discuss the prospects of a Covid-19 vaccine, which the whole nation, indeed the whole world, is waiting on with bated breath. The CDC has told states to be ready to distribute a vaccine by November. The letter notes that...
Read more
“Cures will become the norm” over the next decade – due to life sciences innovation

“Cures will become the norm” over the next decade – due to life sciences innovation

Jan 24, 2020 | ICER, Issues, News

Over the next decade, patients living with chronic conditions and rare diseases can expect groundbreaking new treatments, one-time cures and personalized therapies, a new report by the leading experts in the life sciences predicts. “Cures will become the norm, not the...
Read more

A dangerous plan for rationing essential prescription drugs

Aug 6, 2019 | ICER, News, QALY

The midterms are over and it’s time to get back to discussing issues that impact Americans on a daily basis. Things like health care and, specifically how to reduce costs. President Trump has made lowering the cost of prescription drugs one of his priorities. It seems...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Rural Hospital Closures Further Complicates Healthcare Access in Mississippi
  • Contract Changes Leave DoD TRICARE Beneficiaries Without Pharmacy Access
  • Most Popular Podcast Episodes in 2022 From Patients Rising
  • Patients Rising Now Signs onto Letter to President on Alzheimer’s Scans
  • PRN and 17 Patient Groups Send Letter to Hill on Home Health Cuts

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now